Omeros (OMER) Long-Term Investments (2015 - 2018)
Omeros' (OMER) quarterly Long-Term Investments came in at $1.2 million in Q4 2018, down 80.22% year-on-year from $5.8 million in Q4 2017, and down 80.22% quarter-over-quarter from $5.8 million in Q4 2017.
Omeros (OMER) Long-Term Investments (2015 - 2018) Analysis & Trends
Omeros has disclosed Long-Term Investments across 4 years of filings, most recently posting $1.2 million for Q4 2018.
- Long-Term Investments for Q4 2018 came in at $1.2 million, down 80.22% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.2 million (down 80.22% YoY), and the FY2018 annual result was $1.2 million, down 80.22% from the prior year.
- Long-Term Investments came in at $1.2 million for Q4 2018 at Omeros, down from $5.8 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $10.7 million in Q4 2015 to a low of $1.2 million in Q4 2018.
- The 4-year median for Long-Term Investments is $5.8 million (2016), against an average of $5.9 million.
- Across the five-year window, Long-Term Investments changed 0.0% in 2017 and slumped 80.22% in 2018, its largest moves.
- Omeros' Long-Term Investments stood at $10.7 million in 2015, then slumped by 45.36% to $5.8 million in 2016, then changed by 0.0% to $5.8 million in 2017, then sank by 80.22% to $1.2 million in 2018.
- The last three Long-Term Investments figures came in at $1.2 million (Q4 2018), $5.8 million (Q4 2017), and $5.8 million (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 5.84 Mn |
| Dec 31, 2016 | 5.84 Mn |
| Dec 31, 2015 | 10.68 Mn |